Stay updated on Amivantamab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Colorectal Cancer Clinical Trial page.

Latest updates to the Amivantamab in Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe updates consist of added/removed date entries (e.g., 2025-12-19, 2025-12-18, 2025-12) and a milestone of 2030-10-31, reflecting metadata changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoChange DetectedAdded a Locations section listing study sites across the US, Canada, Belgium, China, Germany, and more. The HHS Vulnerability Disclosure link was removed and revision tags updated (v3.3.3).SummaryDifference0.9%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision changed from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision banner updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedA new trial site has been added: Tainan, Taiwan, 704 (as of 2025-11-07). The page also removed an old government funding/status notice (last updated around 2025-10).SummaryDifference0.4%

- Check67 days agoChange DetectedThe study sites list appears to have expanded across multiple countries, reflecting updated recruitment locations. The last update timestamp on the record has been refreshed.SummaryDifference0.3%

Stay in the know with updates to Amivantamab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Colorectal Cancer Clinical Trial page.